Share Name Share Symbol Market Type Share ISIN Share Description
Collagen Sol LSE:COS London Ordinary Share GB00B94T6Y14 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.125p +4.55% 2.875p 2.75p 3.00p 2.875p 2.75p 2.75p 922,057 11:28:42
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 3.9 -1.6 -1.0 - 9.33

Collagen Sol Share Discussion Threads

Showing 576 to 599 of 600 messages
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
DateSubjectAuthorDiscuss
06/12/2017
21:47
an important nugget of info is also the permission to supply and trade by the Chinese government, that's a hurdle crossed to the biggest developing market in the world.
jacobjohn7
06/12/2017
21:41
as most who are invested know is that the customer list continues to grow the products in development continue to grow, there are some astute funds invested and continue to be so. The news which will come is the results of the long term scans and outcomes of 8 years if these are favourable (they were already at 6 month stage) then that will be the longest proven record for any comparable product on the market, then the CE mark reapproval will follow, this is just one product, and then they will step up the value chain. I continue to wait, and yes if youre not a day trader pecking little bits of profits or losses here and there then you do your calculations, find the right company and wait for the favourable times. dyor. all the best
jacobjohn7
06/12/2017
12:21
The non-exec chairman invested at least £1m of his own cash as shown by six purchases since March 2015. His paper loss on these transactions is £400k so at least he is motivated to turn things around.
columbarius
06/12/2017
08:50
Continues to disappoint/ only people getting fat on this crock of sh#t are the execs
interstellar
05/12/2017
16:25
Management expects to increase sales by 5 times when 2021 comes around and today result didn’t help their cause. The fall in revenue came from lower sales in North America and Asia. The first six-month saw losses grew to £1.38m, the expectation of a higher revenue didn’t materialise. Crucially, they have enough financing in place with Cash and cash equivalent at £6.74m. But, the company didn’t allude to net funds dropping from £7.07m to £3.8m in six months. Mostly due to increases in debt. Collagen paid deferred consideration of £1m to NZ based Southern Lights Biomaterials (an acquisition made in 2014) by drawing down a £1m bond with an interest rate of 10%. Bad news and lack of confidences from lenders. To understand 7 things Collagen Solutions, click http://bit.ly/2jgYt9o
walbrock82
22/11/2017
11:46
I'm not sure if the medics have much faith in some of the concepts. f
fillipe
27/10/2017
07:10
fillipe - Agreed - Interesting and needed product - provided if performs as promised but going nowhere fast - Marked down 1st thing and what appear to be significant sells coming through -
pugugly
26/10/2017
17:16
Hi Pug, you're welcome. I'm not in here, but keep a watch. I had COS early 2016 for a small gain, but then lost out later that year on a re-buy. It's their forever losing the precious £££; which I couldn't take, even for a pharma it gets tiring. There's great talking the talk there, but it must be wearing a bit thin, although the words of future success seem to slip along with ease. I'll keep watching for now as I think you are correct about future falls .....some of the past subscribers must be well cheesed off. Dec 5 for the int's seems light years away. gl and all best, g
fillipe
26/10/2017
16:02
fillipe: Thansk for heads up Could be further falls tomorrow then.
pugugly
26/10/2017
16:01
Disappointing sales. Heard this excuse about delays in customer's projects before and quite unacceptable after the first such occurence. Budget should reflect these probabilities/ possibilities since they seem to be a recurring theme. Need more irons in the fire to compensate. Getting mighty fed up waiting for this lot to perform
interstellar
26/10/2017
15:26
Downgraded to Sell sign raised by Hot Stock Rockets, today. f
fillipe
26/10/2017
15:19
Looking very soggy Sales volume building towards close - Not a GSK but share price action similar !!
pugugly
28/9/2017
13:34
Investor presentation by Collagen Solutions CEO Jamal Rushdy at the Hardman & Co’s Investors Forum 20th September 2017. Http://www.piworld.co.uk/2017/09/27/collagen-solutions-cos-hardman-cos-investor-forum-presentation-september-2017/ Collagen Solutions develops, manufactures and supplies medical grade collagen biomaterials for use in research, medical devices, and regenerative medicine. Introduction – 00:20 Regenerative medicine – 00:44 What Collagen Solutions do: 2:17 How will Collagen Solutions Grow? – 4:12 About collagen and tissue biomaterials – 7:00 Growing the core biomaterials business – 8:32 The competition – 12:00 Collagen Solution’s USP – 13:05 Proprietary products pipeline – 15:04 Financial Highlights – 18:36 Growth & investor proposition – 19:00 Q&A Knee surgery recovery – 19:45 The regulatory process – 20:28 Demand & supply of collagen – 21:41 Why bovine tissue? & immune reaction? – 22:50
tomps2
25/9/2017
08:52
Thanks tim. CE mark nailed on. Timescale after operation study and stats no one in the world can match. Very happy to watch this one build... whilst being invested, I bought a portion slightly higher like others, but I've also averaged down considerably. DYOR
jacobjohn7
22/9/2017
00:23
Collagen Solutions were at the Hardman Conference last night, Jamal had a 20 min slot followed by Q&As, he talked about this extended trial and was emphasising its importance, a couple of the Q&As at the end were on the extended study too. It was recorded on video, so it should be available on the Hardman web site shortly, there is also a new Hardman research report updated to reflect recent progress on their web site too http://www.hardmanandco.com/docs/default-source/company-docs/collagen-solutions-plc-documents/21.09.17-engineering-towards-ce-mark.pdf
timbo003
21/9/2017
17:32
Glad you said that inter I feel exactly the same. I bought at 7p but my waiting has turned me into a skeleton.
1toad
21/9/2017
07:30
I admire such consistent and patient enthusiasm. I am 60% down on my investment and i'm getting a bit tired of these jam tomorrow announcements and still the share price goes nowhere.
interstellar
21/9/2017
07:08
Positive announcement again this morning. If they can get CE mark, that's a large market for them to aim at.
18bt
30/8/2017
19:36
anyone get any titbits from agm?
jacobjohn7
23/8/2017
13:08
Any thoughts on timings etc for the CE mark etc? They could be waiting to make an impact at the AGM?
jacobjohn7
28/7/2017
08:17
you mean figures wise dan? When the inhouse products get approval and release we will move.
jacobjohn7
26/7/2017
20:15
Link to Hardman report (dated July 25th 2017) referred to above: http://www.hardmanandco.com/docs/default-source/company-docs/collagen-solutions-plc-documents/cos---2017-results---25-july-2017.pdf
timbo003
26/7/2017
10:16
The report from Hardman was slightly less positive than their previous report of 2 months earlier
danieldruff2
25/7/2017
10:44
Read the report, and all seems well, obviously there are several intangibles at this stage, that if all come to fruition, could make this a very big company!
jacobjohn7
Chat Pages: 24  23  22  21  20  19  18  17  16  15  14  13  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20171213 17:08:49